Pharmaceutical composition for the treatment of chronic obstructive pulmonary disease and bronchial asthma

A bronchial asthma and chronic obstructive technology, applied in the direction of drug combination, active ingredients of heterocyclic compounds, pharmaceutical formulations, etc., can solve problems such as narrow therapeutic window, achieve the effect of avoiding side effects, reducing side effects, and low price
CN101530618AInactive Publication Date: 2009-09-16莫始平
0 Cites 7 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
莫始平
Publication Date
2009-09-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a pharmaceutical composition for the treatment of chronic obstructive pulmonary disease (COPD) and bronchial asthma, which is composed of a glucocorticoid, a bronchodilator and a pharmaceutically acceptable auxiliary material or carrier; the composition is a preparation for oral use. The glucocorticoid in the inventive pharmaceutical composition is selected from prednisone, prednisolone, methylprednisolone, betamethasone, decamethasone or hydrocortisone; the bronchodilator is selected from formoterol, clenbuterol, procaterol or theophylline. The inventive composition has better therapeutic effect on the COPD and the bronchial asthma than independent administration of two ingredients, and has synergistic effect. The composition has easily-available raw materials, inexpensive price and increased medicine taking compliance as well as plays a significant role in preventing and treating the COPD and the bronchial asthma of patients in vast rural areas and patients in low-income class of the city in China.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition for treating chronic obstructive pulmonary disease (COPD) and bronchial asthma, in particular to a pharmaceutical composition composed of a glucocorticoid (Glucocorticoid) and a bronchodilator (Bronchodilator) and a pharmaceutically acceptable A pharmaceutical composition composed of auxiliary materials or carriers, the composition is in the form of oral preparations. Background technique

[0002] Chronic obstructive pulmonary disease (COPD) and bronchial asthma are the two most common and frequently occurring diseases of the respiratory system, among which COPD is a preventable and treatable disease characterized by airflow limitation, which is not completely reversible , which develops progressively and is associated with an abnormal inflammatory response of the lungs to noxious gases or particles. At present, it is generally believed that the mechanism of its occurrence is: chronic inflammation ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More